Literature DB >> 26569526

Mechanisms and management of dry eye in cataract surgery patients.

Christine Sutu1, Hideki Fukuoka, Natalie A Afshari.   

Abstract

PURPOSE OF REVIEW: To provide a summary of the mechanisms that may cause dry eye after cataract surgery and discuss available and upcoming treatment modalities. RECENT
FINDINGS: Development or worsening of dry eye symptoms after cataract surgery is multifactorial with corneal nerve transection, inflammation, goblet cell loss, and meibomian gland dysfunction commonly cited as underlying disorders. With increasing awareness of the prevalence of dry eye disease, current surgical techniques are being analyzed for their contribution to the issue. Although many classic interventions, such as artificial tears and anti-inflammatory drops, remain first-line treatment options, they may not adequately address abnormalities of the tear film. The trend has been to create new drugs and technologies that target meibomian gland deficiencies and restore goblet cell numbers.
SUMMARY: Therapy for postoperative dry eye symptoms should be determined based on symptom severity and which underlying cause is most prominent at a given time. Patients with high-level risk factors for dry eye should be evaluated preoperatively to determine whether they have preexisting dry eye disease or if they are susceptible to developing disease after surgery.

Entities:  

Mesh:

Year:  2016        PMID: 26569526     DOI: 10.1097/ICU.0000000000000227

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  29 in total

1.  Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.

Authors:  Lian Cui; Ying Li; Hyo Seok Lee; Jee Myung Yang; Won Choi; Kyung Chul Yoon
Journal:  Int Ophthalmol       Date:  2017-08-18       Impact factor: 2.031

2.  Alterations in the ocular surface and tear film following keratoplasty.

Authors:  Jay J Meyer; Akilesh Gokul; Michael T M Wang; Justin Sung; Jennifer P Craig
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

3.  Evaluation of the safety and efficacy of therapeutic bandage contact lenses on post-cataract surgery patients.

Authors:  Dan-Na Shi; Hang Song; Tong Ding; Wei-Qiang Qiu; Wei Wang
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

4.  Dry Eye and Phacoemulsification Cataract Surgery: A Systematic Review and Meta-Analysis.

Authors:  Qiang Lu; Yi Lu; Xiangjia Zhu
Journal:  Front Med (Lausanne)       Date:  2021-07-08

Review 5.  Dry Eye Management: Targeting the Ocular Surface Microenvironment.

Authors:  Xiaobo Zhang; Vimalin Jeyalatha M; Yangluowa Qu; Xin He; Shangkun Ou; Jinghua Bu; Changkai Jia; Junqi Wang; Han Wu; Zuguo Liu; Wei Li
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

6.  Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study.

Authors:  Georgios Labiris; Panagiota Ntonti; Haris Sideroudi; Vassilios Kozobolis
Journal:  Eye Vis (Lond)       Date:  2017-05-10

Review 7.  Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease.

Authors:  Antonio José Mateo Orobia; Jorge Saa; Alberto Ollero Lorenzo; José María Herreras
Journal:  Clin Ophthalmol       Date:  2018-03-06

Review 8.  The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board.

Authors:  Maurizio Rolando; Emilia Cantera; Rita Mencucci; Pierangela Rubino; Pasquale Aragona
Journal:  Int Ophthalmol       Date:  2017-04-10       Impact factor: 2.031

9.  Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution.

Authors:  Eleonora Favuzza; Michela Cennamo; Lidia Vicchio; Fabrizio Giansanti; Rita Mencucci
Journal:  Clin Ophthalmol       Date:  2020-06-26

10.  Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism.

Authors:  Majid Moshirfar; Nour Bundogji; Alyson N Tukan; James H Ellis; Shannon E McCabe; Ayesha Patil; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Clin Ophthalmol       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.